Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 9.03 is in line with its 5-year average of 9.32, around the middle of its 5-year range (0.00–21.08).
As of the fiscal period ended Tuesday, June 30, 2026. 25.12% below its 12-month average of 12.06.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 9.03.
QUICK RATIO (ACID-TEST)
9.03
QUICK RATIO (ACID-TEST) AVG TTM
12.06
QUICK RATIO (ACID-TEST) AVG 3Y
9.30
QUICK RATIO (ACID-TEST) AVG 5Y
9.32
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-25.12%
CURRENT VS 3Y AVG
-2.90%
CURRENT VS 5Y AVG
-3.10%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.25
median of 789 covered companies
CURRENT VS SECTOR MEDIAN
+177.95%
vs the sector median at left
NewAmsterdam Pharma Company N.V.
Market Cap
$2.58B
Quick Ratio (Acid-Test)
9.03
TTM Avg
12.06
3Y Avg
9.30
5Y Avg
9.32
Market Cap
$2.59B
Quick Ratio (Acid-Test)
14.57
TTM Avg
8.96
3Y Avg
7.17
5Y Avg
6.28
Market Cap
$2.58B
Quick Ratio (Acid-Test)
1.62
TTM Avg
1.73
3Y Avg
1.84
5Y Avg
1.83
Market Cap
$2.65B
Quick Ratio (Acid-Test)
2.91
TTM Avg
2.57
3Y Avg
2.71
5Y Avg
4.41
Market Cap
$2.67B
Quick Ratio (Acid-Test)
18.08
TTM Avg
24.41
3Y Avg
20.74
5Y Avg
20.74
Market Cap
$2.67B
Quick Ratio (Acid-Test)
1.16
TTM Avg
1.32
3Y Avg
1.06
5Y Avg
0.97
Market Cap
$2.68B
Quick Ratio (Acid-Test)
1.56
TTM Avg
1.27
3Y Avg
1.12
5Y Avg
1.27
Market Cap
$2.43B
Quick Ratio (Acid-Test)
24.14
TTM Avg
21.55
3Y Avg
17.24
5Y Avg
12.65
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NewAmsterdam Pharma Company N.V. (NAMS) | $2.58B | 9.03 | 12.06 | 9.30 | 9.32 |
| Beam Therapeutics Inc. (BEAM)vs › | $2.59B | 14.57 | 8.96 | 7.17 | 6.28 |
| Privia Health Group, Inc. (PRVA)vs › | $2.58B | 1.62 | 1.73 | 1.84 | 1.83 |
| Neogen Corporation (NEOG)vs › | $2.65B | 2.91 | 2.57 | 2.71 | 4.41 |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.67B | 18.08 | 24.41 | 20.74 | 20.74 |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.67B | 1.16 | 1.32 | 1.06 | 0.97 |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.68B | 1.56 | 1.27 | 1.12 | 1.27 |
| Precigen, Inc. (PGEN)vs › | $2.73B | 3.89 | 3.79 | 3.02 | 3.31 |
| Disc Medicine, Inc. (IRON)vs › | $2.43B | 24.14 | 21.55 | 17.24 | 12.65 |
| Clover Health Investments, Corp. (CLOV)vs › | $2.40B | 1.50 | 1.54 | 1.54 | 1.56 |
Quick Ratio
9.03
Excludes inventory
Current Ratio
9.03
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 9.03 |
| 2026-03-31 | 9.76 |
| 2025-12-31 | 7.88 |
| 2025-09-30 | 12.57 |
| 2025-06-30 | 21.08 |
| 2025-03-31 | 19.98 |
| 2024-12-31 | 8.08 |
| 2024-09-30 | 10.61 |
| 2024-06-30 | 9.83 |
| 2024-03-31 | 8.17 |
| 2023-12-31 | 6.95 |
| 2023-09-30 | 0.00 |
| 2023-06-30 | 10.15 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 13.26 |
| 2022-09-30 | 13.26 |
| 2022-06-30 | 8.38 |
| 2022-03-31 | 8.38 |
| 2021-12-31 | 5.96 |
| 2021-09-30 | 5.96 |
| 2021-06-30 | 10.27 |
| 2021-03-31 | 6.73 |
| 2020-12-31 | 7.90 |
| 2020-09-30 | 0.72 |
| 2020-06-30 | 0.72 |
| 2020-03-31 | 0.72 |
